oral semaglutide vs subcutaneous semaglutide PDF] Effect of Compared With Placebo and on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial Retrospective Comparative Study of Oral

The drug does not solve the appetite-suppression-to-quality-of-life tradeoff

Research indicates a 75.8% reduction after massive weight loss, enabling patients to be more active and enjoy a better quality of life

However, compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness, or quality

15,57 Notably, liraglutide exhibits relatively clear anti-fibrotic effects among GLP-1RAs, although statistically significant improvements in fibrosis were not observed in clinical trials

The trial paired two kinds of measurement

Potential B12 absorption issue Semaglutide delays stomach emptying, which may also impact the absorption of food